Kai Dai

机构：East China University of Science and Technology, Wuhan University, Renmin Hospital of Wuhan University · ORCID：0000-0002-6551-8463

发表论文 40 篇 · 总被引 1212 次 · h-index 17

代表论文

• Mesenchymal stromal cells: promising treatment for liver cirrhosis (2022 · Stem Cell Research & Therapy · 被引 65)
• Biomaterial design for regenerating aged bone: materiobiological advances and paradigmatic shifts (2024 · National Science Review · 被引 57)
• A BMP-2–triggered in vivo osteo-organoid for cell therapy (2023 · Science Advances · 被引 41)
• Upconversion-based intelligent dual-mode hydrogel nanosensor for visual quantitative detection of formaldehyde (2023 · Chemical Engineering Journal · 被引 27)
• Engineering Neutrophil Immunomodulatory Hydrogels Promoted Angiogenesis (2022 · ACS Applied Materials & Interfaces · 被引 25)
• Sulfated oligosaccharide activates endothelial Notch for inducing macrophage-associated arteriogenesis to treat ischemic diseases (2023 · Proceedings of the National Academy of Sciences · 被引 21)